TNFRSF14

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA006404

Antibody CAB026150

Antibody CAB030007

Tissue

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

A majority of malignant cells were negative or displayed weak cytoplasmic immunoreactivity. Some renal cancers and colorectal cancers showed moderate to strong staining. Several cases of malignant melanomas and lymphomas along with colorectal, ovarian, lung, urothelial and renal cancers showed weak to moderate cytoplasmic staining. Remaining malignant cells were generally negative. Malignant lymphomas showed moderate to strong cytoplasmic staining. Most malignant melanomas along with several cases of prostate, colorectal, renal and urothelial cancers displayed moderate to strong membranous and cytoplasmic staining. Remaining cancer tissues were weakly stained or negative.

Literature conformity

Partly consistent with extensive gene/protein characterization dataPartly consistent with extensive gene/protein characterization dataConsistent with extensive gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected